Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
5000 participants
OBSERVATIONAL
2020-04-29
2025-04-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The psychosocial consequences of this health crisis will persist long after restriction measures are lifted and the pandemic is over. This impact will be significant for individuals facing unique contexts or challenges (e.g., older adults, individuals living with a disability, underprivileged families) and will most likely exacerbate existing social and gender inequalities in health and human development.
There is an urgent need for information on the evolution of the psychosocial dimensions of health and coping strategies used by our population and our health and social services structures. Thus, this study is designed to accelerate the availability of high-quality, real-time evidence within health and social services structures to address, support and minimize psychosocial consequences of the COVID-19 pandemic. Through constantly evolving research questions responsive to the course of the pandemic evolution, the rapid system transformations and adaptation of services, and knowledge users (KUs) needs, MAVIPAN aims to address, document, monitor, and evaluate the following:
1. Individuals and families' adjustments and mitigation strategies, especially for those considered vulnerable and in high-risk contexts.
2. Healthcare and social services workers and managers' adjustments and mitigation strategies.
3. The organization of service structures.
4. The social and economic response.
To achieve these objectives, we use a mixed methods study design that combines quantitative questionnaires and qualitative interviews to deepen our understanding of elements such as the coping strategies used during the pandemic. A first measure was taken during lock-down as well as a follow-up at 3 months. Another follow-up will be made at 7 months. At least one per year follow-up will be made over the course of the study (5 years). Additional measures may be taken depending on the evolution of the pandemic and the sanitary measures put in place by the authorities.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Student-delivered Telehealth Program for COVID-19 Education and Health Promotion
NCT04492527
PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics
NCT04609371
Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Mild COVID-19 Patients in Brazil
NCT05197647
Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic
NCT04383470
The COVID-19 and Healthcare Workers: An Active Intervention
NCT04497415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention, this is an observational study that uses validated questionnaires and qualitative interviews..
No intervention, this is an observational study that uses validated questionnaires and qualitative interviews.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Age under 14
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VITAM: Research Center on Sustainable Health
UNKNOWN
Centre de recherche CERVO
UNKNOWN
Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale
OTHER
Centre de recherche universitaire sur les jeunes et les familles
UNKNOWN
Réseau québécois de recherche sur le vieillissement
UNKNOWN
Participation sociale et villes inclusives
UNKNOWN
Société inclusive
UNKNOWN
CISSS de Chaudière-Appalaches
OTHER_GOV
Centre intégré de santé et de services sociaux de la Côte-Nord
UNKNOWN
Fondation Mirella et Lino Saputo
UNKNOWN
Ville de Québec
UNKNOWN
Living Lab de Charlevoix
UNKNOWN
Centre intégré de santé et de services sociaux du Bas St-Laurent
UNKNOWN
Réseau provincial de recherche en adaptation réadaptation
UNKNOWN
Réseau international sur le Processus de production du handicap
UNKNOWN
Centre de recherche intégrée pour un système apprenant en santé et services sociaux
UNKNOWN
Regroupement des organismes de personnes handicapées de la région 03
UNKNOWN
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Annie Leblanc
Full Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annie LeBlanc, PhD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medecine, Laval University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VITAM-Research Center in Sustainable Health
Québec, , Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
LeBlanc A, Baron M, Blouin P, Tarabulsy G, Routhier F, Mercier C, Despres JP, Hebert M, De Koninck Y, Cellard C, Collin-Vezina D, Cote N, Dionne E, Fleet R, Gagne MH, Isabelle M, Lessard L, Menear M, Merette C, Ouellet MC, Roy MA, Saint-Jacques MC, Savard C; MAVIPAN Research Collaboration. For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol. BMJ Open. 2022 Apr 4;12(4):e048749. doi: 10.1136/bmjopen-2021-048749.
Related Links
Access external resources that provide additional context or updates about the study.
Official web site of the study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
To be assigned
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.